Industrial Microbiology Market - Databook 2025 to 2034

The global industrial microbiology market size was evaluated at USD 14.11 billion in 2024 and is expected to grow around USD 26.15 billion by 2034, registering a CAGR of 6.36% from 2025 to 2034.

Highlights of the Industrial Microbiology Market

• North America registered the largest revenue share in 2024.
• Europe is anticipated to grow at the fastest rate in the market during the forecast period.
• By product, the reaction consumables segment held a dominant presence in the market in 2024.
• By product, the equipment and systems segment is expected to grow at the fastest rate in the market during the forecast period of 2025 to 2034.
• By test, the sterility testing segment accounted for a considerable share of the market in 2024.
• By test, the water and environmental testing segment is projected to experience the highest growth rate in the market between 2025 and 2034.
• By end-use, the pharmaceutical biotechnology segment led the industrial microbiology market.
• By end-use, the food and beverages segment is set to experience the fastest rate of market growth from 2025 to 2034.

Industry Valuation and Growth Rate Projection

The industrial microbiology market talks about an applied section of microbiology that uses microorganisms for the manufacture of goods and services of financial worth. It makes use of microbes such as bacteria, fungi, and yeasts for producing antibiotics, food products, fuels, enzymes, drugs, amino acids, vaccines, and fine chemicals. This field of science can be applied in areas like wine and beer production, pharmaceuticals, diagnostic and testing services, agricultural products, and industrial enzymes.

This area of science can offer several possibilities to promote the use of biodegradable materials instead of plastics, thus lessening the carbon footprint on a global scale.

Some scientists are certain that bacteriophages, or phages, can treat diseases across the globe that cannot be treated any other way. Antimicrobial resistance (AMR) is one of the most dangerous diseases that can be treated through phage therapy. In the US, doctors can ask for emergency approval from the FDA to utilize this therapy when no other treatment options are left.

Industrial Microbiology Market: Stats and Figures

• According to the research published in the International Dairy Journal, 5% to 15% of the dry weight of all living cells is found within nucleic acids, which are vital biotic molecules functioning as the most important carriers of genetic information in all life forms.
• According to the UNFCCC, in countries like the United States, nearly one-third of total food is thrown away, which causes greenhouse gas emissions globally.
• According to Smithsonian Institution, over 80% of the world’s species and a high number of microorganisms can be acquired from the oceans.

Industry Leader Announcements

• Amine Raji, co-founder and Chief Executive at Spore.Bio:

Talking about how artificial intelligence can bring change in the industrial microbiology sector, Raji said, “AI is nice for chatbots and LLMs, but some amazing, niche applications are paving the way for deep changes in certain industries, especially science-related industries. We are proud of being an example of it, while having developed in only one year our proprietary AI-based technology that manages to do what existing technologies couldn’t for two centuries.”

How Has AI Benefitted the Industrial Microbiology Market?

Artificial intelligence-based algorithms and tools are helping the industrial microbiology sector to grow on a large scale globally. Here’s how the industrial microbiology market has benefited from AI immeasurably:

• Natural Language Processing: The NLP technology of AI can automate document authentication and save time.
• Data analysis: Due to AI’s property of studying immense data speedily, it can restructure processes and reduce energy consumption.
• Prediction: AI can foresee whether or not any tool or equipment will work well, thus avoiding industry-related problems and saving costs.
• Machine learning: Using machine learning, AI can identify patterns and data to see how the sanitation standards are met as much as possible.

Recent Developments:

• In February 2025, ExxonMobil Signature Polymers and Colombian packaging manufacturer Alico joined hands to create packaging solutions for local meat producers.
• In December 2024, Dr. Changzhu Wu of the University of Southern Denmark developed a polymer coating for Escherichia coli (E. Coli) to help it better withstand less than ideal laboratory conditions, a breakthrough for the biotech workhorse.
• In October 2024, Researchers at the U.S. Department of Energy’s Bioenergy Technologies Office (BETO) funded Agile BioFoundry (ABF) and the Advanced Biofuels and Bioproducts Process Development Unit (ABPDU) built a partnership with Industrial Microbes to fruitfully boost a bio-based process.

Geographical Insights 

The industrial microbiology market is experiencing significant growth worldwide, with concentrated growth in North America maintaining its position as the dominant region while Europe emerges as the fastest-growing market. The market of the APAC region is getting ahead at a steady pace.

North America

The market in North America has maintained an influential position owing to companies formulating new products using microbiology. The large number of biotechnology firms are leading research and development efforts in the region. With a lifestyle shift toward gut-healthy, plant-based products, and clean farming the demand for these engineered microbes is high in the food and beverage industries as well as in agriculture.

Ferment has introduced a new fund of $20 million for the studio to convert natural science into products helpful throughout diverse sectors such as energy, agriculture, materials, and health. 

Europe

The European market is leading the way forward, given that the companies in the region are reinventing microbiology testing. Technological advances, and government support in the form of European Technology Platforms was one of the initiatives launched by the European Commission in 2003.

Paris-based company Spore. Bio announced that it has raised $23M to transform microbiology testing by drastically reducing the processing time.

Asia Pacific

The industrial microbiology market in the Asia Pacific region is growing at a steady pace as a consequence of the big companies supporting the budding firms in research and development. The market in Asia Pacific is expanding rapidly due to rising investments in biotechnology, and a growing focus on microbial research.

NSG BioLabs has formed a collaboration with Merck Singapore to make resources and expertise available to biotechnology start-ups with an aim to reinforce the research and development competencies of NSG BioLabs' occupants.

Competitive Landscape 

The industrial microbiology market is highly competitive, with leading pharmaceutical companies such as Johnson & Johnson, Pfizer, Merck KGaA, Roche Diagnostics, Danaher Corporation, GSK, AbbVie, Amgen, AstraZeneca, Qiagen NV, and Sartorius AG holding the highest market share. Emerging biotech firms also play a crucial role by fostering a dynamic and evolving competitive landscape.

The market is dominated by several pharmaceutical companies renowned for their significant contributions to research in the field of industrial microbiology. Based on fresh data, the top three leading companies are:

• Company Name: Johnson & Johnson
• Year of Incorporation: 1887
• Headquarters: New Jersey, United States

The yearly revenue of Johnson & Johnson was accounted to be $88,821,000 in 2024.

• Company Name: Pfizer
• Year of Incorporation: 1942
• Headquarters: New York City, United States

The gross profit of Pfizer leaped from $34,599,000 in 2023 to $45,776,000 in 2024.

• Company Name: Merck KGaA
• Year of Incorporation: 1668
• Headquarters: Darmstadt, Germany

The annual revenue of Merck KGaA was positioned at $21,156,000 in 2024.